Overview
Evidence-based recommendations on enzyme-linked immunosorbent assay (ELISA) tests for therapeutic monitoring of tumour necrosis factor (TNF)-alpha inhibitors in rheumatoid arthritis. The tests are Promonitor, IDKmonitor, LISA‑tracker, RIDASCREEN, MabTrack, and those used by Sanquin Diagnostic Services.
Last reviewed: 10 July 2010
Diagnostics guidance 36 has been migrated to HealthTech guidance 521. The recommendations and accompanying content remain unchanged.
This guidance replaces the NICE medtech innovation briefing on promonitor for monitoring response to biologics in rheumatoid arthritis (MIB126).
Next review: This guideline will be reviewed if there is new evidence that is likely to change the recommendations.